Advanced search
Publication Cover
Acta Oncologica Volume 54, 2015 - Issue 7
Journal homepage
3,414
Views
7
CrossRef citations to date
0
Altmetric
Letter

Promising management of pazopanib-induced liver toxicity

Myrella VlenterieDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, the NetherlandsCorrespondence[email protected]
,
Nielka P. van ErpDepartment of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands
&
Winette T. A. van der GraafDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
Pages 1064-1066 | Received 29 Dec 2014, Accepted 30 Dec 2014, Published online: 03 Mar 2015

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yi-Kun Wang, Xiao-Nan Yang, Wei-Qing Liang, Yao Xiao, Qi Zhao, Xue-Rong Xiao, Frank J. Gonzalez & Fei Li. (2019) A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice. Xenobiotica 49:6, pages 655-670.
Read now
Pascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, Olivier Huillard, Anne Jouinot, Jennifer Arrondeau, Audrey Thomas-Schoemann, Michel Vidal, Jérôme Alexandre & François Goldwasser. (2016) Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1433-1444.
Read now

Articles from other publishers (5)

Hana Studentova, Jindriska Volakova, Martina Spisarova, Anezka Zemankova, Kvetoslava Aiglova, Tomas Szotkowski & Bohuslav Melichar. (2022) Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature. BMC Gastroenterology 22:1.
Crossref
Camille Houron, Marie Danielou, Olivier Mir, Bernard Fromenty, Gabriel Perlemuter & Cosmin Sebastian Voican. (2021) Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians. Critical Reviews in Oncology/Hematology 157, pages 103127.
Crossref
Arie J. Verschoor, Fabiënne A. R. M. Warmerdam, Tjalling Bosse, Judith V. M. G. Bovée & Hans Gelderblom. (2018) A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report. BMC Cancer 18:1.
Crossref
Remy B. Verheijen, Jos H. Beijnen, Jan H. M. Schellens, Alwin D. R. Huitema & Neeltje Steeghs. (2017) Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing. Clinical Pharmacokinetics 56:9, pages 987-997.
Crossref
. (2015) Pazopanib. Reactions Weekly 1568:1, pages 216-216.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.